![](https://investorshub.advfn.com/uicon/792403.png?cb=1632160976)
Thursday, March 03, 2022 10:41:35 PM
The Enzolytics protocol offers the opportunity to implement A.I. analysis and provides a platform for creating multiple fully human Monoclonal Antibodies targeting conserved immutable sites on the virus and offering a cure for these viruses.
https://samsungbiologics.com/media/company-news-view?boardSeq=1377&schString=enzolytics
The conjecture is that, if Samsung was willing to claim "cure" in an official PR, they must have seen something compelling.
Similarly, Intel titled their ENZC whitepaper as follows:
Optimizing Empathetic AI to Help Healthcare Providers Cure Deadly Diseases
Which twitter has read into just a tiny little bit...
I edit too much! Refresh any of my posts within the first few minutes to get silly little updates and clarifications. :)
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM